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ABSTRACT 
 
Background and Objectives: Varicella Zoster Virus (VZV) infection in pregnant women can cause complications for the 
mother and fetus. The aim of this study was to assess the immunity against VZV among young women before marriage.
Materials and Methods: In this cross-sectional study 250 women attending health centers in Sanandaj, Iran, for pre-marital 
medical check-up were randomly selected. The VZV IgG measured by ELISA and demographic characteristics of partici-
pants including their age, place of residence, number of siblings, occupation, education and history of chickenpox were also 
recorded. Data were analyzed using R statistical software. Association between VZV infection and participants’ characteris-
tics was assessed using Chi-square and Fisher's exact tests.
Results: Out of 250 participants, 178 individuals (71.2%) diagnosed as antibody positive and 72 (28.8%) negative. Our 
findings revealed that the immunity against VZV increased with individuals’ age (P<0.0001) and their number of siblings 
(P= 0.03). Significant association was found between history of chickenpox and immunity (P <0.001).  Positive and negative 
predictive values of self-reported history of chickenpox obtained by 94.60% and 49.25%, respectively.
Conclusion:  A notable percentage of women were found to be susceptible to VZV, hence they are at risk of getting infected 
during pregnancy which in turn may result in fetus abnormalities. Screening the immunity and further studies on the need of 
vaccination before marriage are recommended.
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pesvirus, is the causative agent of varicella (chick-
enpox). The virus becomes latent in neurons and 
recurrent infection causing herpes zoster (shingles) 
in adults. Varicella is a highly contagious disease in 
which the virus enters the host through the mucous 
membranes of upper respiratory tract or conjuncti-
va (1). Although, varicella is a mild and self-limited 
disease, it may motive serious complications or even 
death in healthy adults, pregnant women and immu-
nocompromised patients (2).
The primary infection of VZV in non-immune 
pregnant women may show itself with pneumonia 
and encephalitis in both mother and fetus. Maternal 
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INTRODUCTION
Varicella Zoster Virus (VZV), a human alphaher-
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varicella infection in the early months of pregnancy 
may emerge as congenital varicella syndrome in ne-
onates with symptoms such as low birth weight, limb 
hypoplasia, eye disorder, neurological abnormality 
and developmental delay. VZV infection during the 
third trimester or close to delivery can cause infec-
tion in newborn which may result in increasing the 
mortality rate of infants up to 20%. If the contact 
happens days before and after delivery the risk of de-
veloping neonatal chickenpox is about 17–30% (1-2).
The immunity against VZV has not been yet ful-
ly understood. After development of the rash in pri-
mary infection antibody is produced against VZV 
which remains for many years in blood. This may 
play a role in immunity to VZV. Maternal varicel-
la-zoster immunoglobulin (VZIG) administration 
before rash development can modify the progression 
of the disease (1).
Vaccination against VZV can prevent  the disease. 
The vaccine is made from the Oak strain of live at-
tenuated VZV. Despite the public use of the varicel-
la vaccine during childhood in developed countries, 
routine immunization against varicella has not been 
well established in developing countries such as Iran. 
In the absence of such an active immunization pol-
icy, the vulnerable populations including premarital 
women are at risk of developing the infection (3).
Epidemiology of chickenpox varies between tem-
perate and tropical climates. Incidence of varicella 
varies with respect to population density and risk of 
exposure, social factors, humid conditions, and es-
pecially geographic locations of the world (3). The 
epidemiology of VZV infection has not been under-
stood well in tropical areas where a relatively large 
proportion of adults are seronegative. In temperate 
climate countries like Iran, chickenpox occurs most-
ly during the childhood. Thus a large proportion of 
seroconversion occurs in early adolescence (1). In 
Iran, the level of immunity against VZV has been 
reported from 71.4% to 78.5% in general population 
(4-5) and 76.5% to 86.9% among women at child-
bearing age (6). It appears that antibodies increase 
with age (7).
In the event of physical contact between a non-im-
mune pregnant woman and a chickenpox patient, 
the disease can be transmitted. Some studies have 
reported a significant association between a histo-
ry of chickenpox and the immunity to VZV (2). In 
order to receive either VZIG or antiviral therapy, 
pregnant women should be screened for their im-
munity against VZV using either laboratory tests or 
the history of chickenpox (1). In most cases, chick-
enpox occurs in childhood and therefore the history 
of disease is not clear. Hence, some studies suggest 
counting only those cases with a positive history of 
chickenpox (2). Information about the immunity lev-
els of VZV in young women is also important from 
administration perspective; it helps the health policy 
makers to assess the need for a vaccination program 
as well as the preparation for VZIG.
The main goals of this study were to estimate 1) 
the seroprevalence of IgG antibodies against VZV, 2) 
the positive predictive value (PPV), and 3) negative 
predictive value (NPV) of self-reported history of 
chickenpox in young women before marriage in the 
city of Sanandaj, Iran.
   
MATERIALS AND METHODS
 
   Subjects: In this cross-sectional study, 250 young 
women attending the health centers in Sanandaj for 
premarital examinations were recruited and their in-
formed consent for participation in the research was 
obtained. From every participant 5 ml blood was ob-
tained. The blood samples were placed into a water 
bath at 37°C to form clots. They were centrifuged for 
10 minutes at the 3000 rpm. Sera were aliquoted and 
placed in a freezer at -20°C. 
Demographic information of participants includ-
ing their age, education, occupation, number of sib-
lings, location of residency (rural or urban), and the 
history of varicella infection were collected by in-
terview.
For each specimen, the level of antibody against 
VZV IgG was assessed using ELISA kit (CaptiaTM 
VZV IgG, Trinity Biotech USA) and ELISA reader 
(Hiperion ,Germany). Antibody levels greater than 
0.13 IU/mL considered as positive, 0.11 <equivocal< 
0.13 IU/mL, and lower than 0.11 IU/mL as negative 
according to supplier instruction. 
Statistical analysis: Data were managed in Micro-
soft Excel and analyzed using R statistical software 
version 3.1.3. The Chi-square test, Fisher's exact test, 
and Spearman correlation were used as appropriate 
in order to investigate the statistically significant as-
sociation between the IgG antibodies against VZV 
and participants' characteristics in study. 
Positive predictive value (PPV) and negative pre-
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dictive value (NPV) of self-reported history of chick-
enpox were estimated using the following ratio:
 
RESULTS
Out of 250 young women in the study, 178 (71.2%) 
were diagnosed as antibody-positive and the rest (72 
participants 28.8%) as antibody-negative against 
VZV. The maximum and minimum antibody levels 
were obtained 0.06 and 940.93 IU/mL, respectively. 
The mean level of individuals’ antibody was 37.05 
IU/mL. No borderline (equivocal) antibody level was 
observed; hence any need to rerun the test. 
The age of participants ranged from 13 to 40 years 
with the mean of 22.39 (± 5.4, standard deviation). 
The association between antibody titer and age of 
participants was statistically significant (Spearman 
correlation ρ=0.29, P<0.0001). In addition, the lev-
el of antibodies to VZV increased with age. Fig. 1 
displays seroprevalence pattern of subjects versus 
their age. The bars in the Figure represent 95% con-
fidence intervals. Beginning with 40% and ending up 
with 100% at 31 years of age, seroprevalence showed 
clearly an increasing trend as individuals getting 
aged. The Figure also shows that all women older 
than 31 years were antibody positive whereas this 
was 40% for those in range of 13 to 14 years old.
In comparison of seroprevalence between women 
living in rural area with those living in urban areas, 
there was not any significant difference (Chi-squared, 
P = 0.56). Moreover, no statistically significant asso-
ciation between the level of immunity against VZV 
and participants’ occupation (Fisher exact test, P = 
0.987) and education (Chi-squared, P = 0.295) were 
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observed.
Table 1 reports the seroprevalence of antibodies 
against VZV with respect to the number of siblings. 
As the number of sisters and brothers increased, a 
tendency toward more positive and less negative 
outcomes can be seen. In families with more than 
eight siblings, 83.3% of women showed positive test 
results. The Fisher exact test indicated a significant 
association between the immunity level of partici-
pants to VZV and their family sizes (P = 0.03).
Subjects were also asked about their history of 
chickenpox (Table 2). The total number of 111 indi-
viduals found with positive chickenpox history and 
134 reported negative history.
The distribution of antibody levels showed high-
ly positive skewed distribution hence to obtain sen-
sible estimates, the median ± IQR (interquantile 
range) are reported. The median antibody level of 
women with positive history of chickenpox was 6.86 
± 20.63 IU/ml whereas it was 0.18 ± 5.69 for those 
with negative chickenpox history. Furthermore, out 
of 111 with positive varicella disease history, 105 
subjects identified with positive varicella antibody. 
Fig 1: Varicella Zoster Virus IgG seroprevalence pattern of 
women versus the age (years). Bars represent 95% confi-
dence intervals.
Table 1. The prevalence of antibodies to varicella-zoster virus according to the number of siblings
Siblings
[1-2]
[3-8]
>8
Total
Negative
(antibody level < 0.11 IU/mL)
33 (39.29%)
38 (23.75%)
1 (16.67%)
72 (28.8% )
Equivocal
(0.11 < antibody level< 0.13 IU/mL)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
Positive
(antibody level > 0.13 IU/mL)
51 (60.71%)
122 (76.25%)
5 (83.33%)
178 (71.2%)
Total
84
160
6
250
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From 134 participants with negative varicella dis-
ease history, 68 were negative for varicella anti-
body. Positive predictive value (PPV) and negative 
predictive value (NPV) of self-reported history of 
chickenpox were calculated as 94.59% and 50.74%, 
respectively.
 
DISCUSSION
   The severity of varicella in pregnant women requires 
regular screening strategies to identify susceptible in-
dividuals. The result of this study should provide the 
health policy makers and obstetricians the basic infor-
mation about the potential transmission of the VZV in 
the studied population in order to implement neces-
sary programs such as vaccination schedule, interven-
tion with varicella-zoster immunoglobulin (VZIG), 
and antiviral therapy.  
   In this study, the level of immunity against VZV in 
pre-marital young women was obtained to be 71.2%. 
We also found a direct and significant association be-
tween the immunity level of participants, their age and 
number of siblings. We found 28.8% of women in the 
study were negative for varicella antibody and hence 
vulnerable to VZV. Thus, the potential of virus trans-
mission and complications for mothers and their fetus 
should be considered with care.
   Similar studies in Iranian population have reported 
the immunity against VZV from 72.9% (2) to 90.2% 
(8). Hosseininasab et al. found 89.35% of premarital 
women with serological varicella immunity in Ker-
man, south-east of Iran (9). This was 78.5% in another 
study conducted in Hamadan, the west of country (4). 
Furthermore, in Bushehr, the south of Iran, along the 
coastal region of the Persian Gulf, antibodies against 
VZV was estimated 74.5% among college females 
(10).
  Studies in other countries reported higher rate of 
seroprevalence than what we observed in our study. 
Table 2. The prevalence of antibodies to varicella-zoster virus according to history of chickenpox
History
Positive
Negative
Uncertain
Total
Negative
(antibody level < 0.11 IU/mL)
6 (5.40%)
66 (49.25%)
0 (0%)
72 (28.8% )
Equivocal
(0.11 < antibody level < 0.13 IU/mL)
0(0%)
0(0%)
0(0%)
0(0%)
Positive
(antibody level >0.13 IU/mL)
105 (94.60%)
68 (50.75%)
5 (100%)
178 (71.2%)
Total
111
134
5
250
In a study, UK, Bradford, the seroprevalence of VZV 
among pregnant women reported by 95% (11). In 
Korea, it has been reported by 89.6% among females 
fewer than 80 year of age (12). In spite of vaccina-
tion coverage the prevalence of VZV antibodies has 
found to be 92.8% among young adults in Madrid, 
Spain (13). The overall IgG seroprevalence was 84.3 
% among Croatian women during their fertility period 
(14). All female daycare workers tested seropositive 
for VZV, compared to only 94% of the women not 
working in daycare in Amsterdam (15). Seropreva-
lence of VZV among pregnant women was 80.9% in 
Tunisia (16). In addition to other reasons, the vaccina-
tion against VZV in developed countries may explain 
in part the discrepancy between these results and our 
finding.
   In agreement with our finding, some studies con-
ducted in Iran and other countries also confirmed a 
direct association between immunity to chickenpox 
and age (2, 12, 14, 17-18). However, in a few stud-
ies conducted in Iran, no significant association be-
tween immunity and age was found (6, 8). In our study 
population, the seropositivity increased with age 
and hit 100% at ages over 31 or above. This is 
due to increasing the possibility of VZV transmission 
with age.
  We found the mean marital age 22 years with a se-
ronegative rate of 44.78% at 13-18 age group and 
32.56% among19-23 years women. Thus, routine 
screen for VZV antibodies for women under 30 years 
who report no chickenpox history is recommended.  
   In agreement with our findings, increasing the im-
munity to chickenpox with the numbers of siblings has 
been reported in other studies in Iran (2, 8), Non-signif-
icant association between seroprevalence of VZV and 
education, palace of residence, as well as occupation 
have also been reported (4, 8-10, 14).
   In some studies a significant association between 
history of chickenpox and immunity has been report-
ed. By studying Iranian women with positive history 
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of pre-marital chickenpox, Hosseininasab et al. found 
that 94% were serological varicella immunity and 85% 
of them who were either uncertain or with negative 
history of chickenpox seropositive (9). Pourahmad et 
al. estimate the pre-marital PPV of participants with 
positive history of chickenpox 79.5% and the NPV 
30.5% for those uncertain or with negative history of 
chickenpox (2). Koturoglu et al. studied the seroepi-
demiology of VZV and reliability of varicella history 
in Turkish adolescent population (19). They found the 
NPV about 57.8%decreased with age. Hannachi et al. 
reported PPV and NPV of chickenpox history 84.9% 
and 20.9% respectively in Tunisia population (16). In 
Hong Kong positive immunity was observed among 
95.4% of pregnant women, and those with positive, 
negative, or uncertain history of infection reported 
similar high seroprevalence (96.4, 90.5, and 95.9% 
respectively) (20).
    In our study, 94.59% of women with positive chick-
enpox history were identified as seropositive with 
mean level of antibody higher than those with nega-
tive history of infection. Significant association was 
observed between the history of chickenpox and im-
munity. These findings indicate that the positive histo-
ry of chickenpox can be used alone as a good predictor 
of seropositivity. However, premarital serological test 
is recommended for negative cases.
   In developed countries, vaccination coverage against 
VZV is well developed. Many countries are studying 
the possibility of mass vaccination against varicella 
(21). To develop vaccination programs and appropri-
ate preventive health care measures against the dis-
ease, a good knowledge about the level of immunity 
is important. Hence, in Iranian society, population 
screening should be done across all provinces. How-
ever, since the coverage of varicella vaccination in 
Iran is not yet broadly available, to reduce the risk of 
varicella in women, vaccination before marriage and 
pregnancy is recommended for those who may have 
one or all of the following criteria; i) under 30 years 
old, ii) living in a household less than three siblings, 
and iii) with missing history of chickenpox and im-
munity.
    In conclusions, our findings showed that there were 
a noticeable percentage of young women susceptible 
to varicella. This makes them vulnerable against the 
infection and possibility of the maternal and fetus 
abnormalities. Therefore, screening for immunity of 
young women and further studies on the need of vac-
cine administration before marriage or pregnancy is 
highly recommended.
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